LAUSANNE, SWITZERLAND – Nestlé 2 November inaugurated its new research centre at EPFL, the federal polytechnic institute in Lausanne.
The Nestlé Institute of Health Sciences “is developing the scientific basis for personalised nutrition in the areas of gastrointestinal health, metabolic health, and brain health,” the company said in a statement. “Ultimately, the goal of this research is to promote healthy ageing through personalised nutrition for medical conditions, such as diabetes and Alzheimer’s disease.”
The food company, which is increasingly investing in basic research, notes that “Chronic non-communicable diseases like obesity and diabetes are highly complex. They are the result of a multifaceted relationship between genes, diet and lifestyle – and the nature of this relationship is different for each one of us. A more targeted nutrition that takes account of these complexities requires a deeper understanding of human health and disease, right down to the molecular level.”
The institute’s focus is on health in three main areas: brain, metabolic and gastro-intestinal. It has been working closely for several years with researchers at EPFL, notably in the area of brain research, a basic research field where EPFL is one of the top universities in Europe.
Earlier this week EPFL announced a strategic partnership between one of the brain research startups at the university, and a US company: One Mind for Research and Guardian Angels For Smarter Life (GA) will design a new tool for the treatment of major brain diseases: micro devices that use nanotechnology monitor and transmit biological signals, for One Mind for Research, an independent non-profit organization dedicated to curing the diseases of the brain. The projects will use GA’s Zero Power Biosensor and its potential for analysis, monitoring and treatment of major brain diseases. “This strategic partnership will be a ‘Demonstrator’ platform in GA’s bid for a €1 billion funding grant from the European Union Future and Emerging Technologies,” EPFL says in a press release.